home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  InfoTechPharma 2001  
  January 03, 2001

Computational Genetics / Bioinformatics

 
     
  IBC Life Sciences, The Commonwealth Institute, London.
7 – 9 February 2001


InfoTechPharma 2001 will address all the key sectors in R&D where IT
is creating value for end-users and organisations. It looks at how
this is being done, the problems that must be overcome, and the impact
such changes will have in the future. An exceptional panel of
internationally renowned experts from BIOPHARM, IT support industries and academia will present their approaches to creating value through IT/IS. In addition, presentations from other industries with similar fundamentals of safety, efficacy, strict regulation, big budgets and lengthy product development will also be features.
 
 
Organized by: IBC Life Sciences
Invited Speakers: Neil Kipling
Chairman & CEO
IDBS
UK

Dr Neil Stutchbury
Global Vice President of R&D IS
AstraZeneca
UK

Dr Jack T. Cusma
Mayo Clinic
USA

Paul Mee
Software Design Consultant
Applied Biosystems

Kevan Lucy
Database Specialist
Applied Biosystems

Kevin Jones
Software Design Consultant
Applied Biosystems

J. Lawrence T. Jones
e-Business Strategy Manager
Origin UK Limited
UK

Dr David Wadsworth
Head of Business Support & Development
Novartis Pharma AG
Switzerland

Dr Christoph Loeffler
Global Head of IT Infrastructure
F. Hoffmann-La Roche Pharmaceuticals
Switzerland

Dr David Benton
Director
Intelligent Information Systems
Advanced Information Technology
SmithKline Beecham Pharmaceuticals
USA

Dr Uwe P. Trinks
CIO & Vice President of Information Technology
Global Safety Surveillance Inc.
USA

Sue Wilson
Research Fellow
Psychopharmacology Unit
University of Bristol
UK

Dr John Norvell
National Institute of General Medical Science (NIGMS)
USA

Dr Jacquelyn Fetrow
Chief Scientific Officer
GeneFormatics Inc.
USA

Dr Manuel Peitsch
Director
Scientific Computing Worldwide
GlaxoWellcome Experimental Research
Switzerland

Professor Janet Thornton
Chief Scientific Officer
Inpharmatica
UK

Dr Kenneth J. Kelly
Research Scientist
Chemical Computing Group Inc.
Canada

Walter S. Woltosz
Chairman and CEO
Simulations Plus Inc.
USA

Dr Ken Clark
Director of Therapeutics
Pharmagene plc
UK

Dr Lorin K. Roskos
Functional Head
Pharmacokinetics and Toxicology
Abgenix Inc.
USA

Dr Philip Watson
Consultant
Pharsight
UK

Dr Mark Sale
Senior Clinical Programme Head
Modelling and Simulation
Glaxo Wellcome Inc.
USA

Dr Rudolph Potenzone
MDL Information Systems (UK) Ltd
UK

Bruce Madge
British Library
UK

Layne Johnson
Pharmacia Corporation
USA

Sue Jackson
Informatics and Services
Roche Discovery Welwyn
UK

Duncan Fyfe
Director
Informatics
Product Strategy and Licensing
AstraZeneca
UK

Dr Michael Hehenberger
Executive Consultant
IBM North America
USA

Paul Coggin, Vice President, Pharmaceutical, Biotech and Healthcare Group
SageMaker Inc.
USA

Dr Paul Weber
Vice President
Software Consulting Services
Tripos Inc.
USA Dr Stephen K. Durham
Distinguished Research Fellow
Lead Safety Assessment
Bristol Myers Squibb Pharmaceuticals
USA

Dr Jonathan Schmidt
Vice President Research and Technology
Nanodesign
Canada

Dr Gail Adam
Gemini Genomics
Sweden

Professor William Bains
CEO
Amedis
UK

Dr Thomas J. Colatsky
Executive Vice President/CSO
Physiome Sciences Inc.
USA

Peter Boogaard
European New Business Development Manager
Applied Biosystems
The Netherlands

Frans Leijse
Senior Validation Consultant
Applied Biosystems
The Netherlands

Urs von Mont
Princicpal Consultant
DAI
Switzerland

Chris Clark
Industry Board and Steering Committee; GAMP Forum
Head
NAPP Pharmaceutical Holdings
UK

Stephen Messenger
Systems Compliance Specialist
NAPP Pharmaceutical Holdings
UK

Dr Guy Wingate
Computer Compliance Manager
Glaxo Wellcome R&D
UK

Dr Steve Gardner
European VP
Viaken
UK

Dr David Parry-Smith
Informatics Director
Cambridge Drug Discovery Ltd
UK

Dr Arthur J. Thomas
Chief Technologist
BioWisdom
UK

Anthony R. Rees
MA
D.Phil.
Director of Science and Member of the Board
Synt:em
France

Professor Prakash Nadkarni
Associate Professor
Center for Medical Informatics
Yale University Medical School
USA

Knut Korsell
Vice President of Sciences
SGI
Germany

Dr Joseph M. Jasinski
Senior Manager
Computational Biology Center
IBM Research
USA

Dr David A. Nielsen
Senior Bioinformatics Specialist
InforMax Inc.
USA

Dr Bryn Roberts
Senior Group Leader of Lead Informatics
AstraZeneca
UK

Dr Michael Schlenkrich
Product Manager
SGI
Germany

Dr Alvis Brazma
Team Leader Microarray Informatics
European Bioinformatics Institute
UK

Dr Beatrice Vincenzi
Data Management and Statistical Unit
Director
Medical & Regulatory Affairs
Bracco S.p.A.
Italy

Axel Rolle
Head of Clinical and Supply Chain Systems
Novartis Pharma AG
Switzerland

Dr Graham Bunn
Global VP Business IT
Domain Pharma Corporation
France

Dr Ian Bradbrook
Head of Phase I
TEAMworks Clinical Services
UK

Dr Peter de Boer
Johnson & Johnson PRI
Belgium

Paul Bleicher
Chairman
Phase Forward Inc.
USA
 
Deadline for Abstracts:
 
Registration:
E-mail: cust.serv@informa.com
 
  Posted by:   C Marshall  
Host: gatekeeper.ibcuk.co.uk
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.